Our index case presented with dysautonomia, a dry cough, neuropathy and cerebellar ataxia at age 50, approximately 38 years after growth hormone (GH) midpoint of treatment, and died 14 months after motor onset. This evidence concerns the gene GH1 and dysautonomia.